Skip to main content
Tuesday, November 11, 2025 - 2:39pm
Quantum computer wide angle visual concept

Here's a look at the recent stock performances and Q3 earnings reports from Rigetti Computing, IonQ and D-Wave Quantum.

Read more
Tuesday, November 11, 2025 - 2:19pm
Tesla CEO Elon Musk

Tesla shares are trading lower after he electric vehicle manufacturer reported steep sales declines in China

Read more
Large Cap, News, Global, Movers
Tuesday, November 11, 2025 - 2:10pm
EVgo fast charging sign with arrow.

EVgo shares dip as JPM trims target, but the company lifts sales outlook and touts dynamic pricing and AV partnerships as growth catalysts.

Read more
Tuesday, November 11, 2025 - 1:55pm
Tyson Foods company logo displayed on mobile phone

Tyson shares rise as pricing catch-up expected to ease cost pressures; chicken strength offsets beef headwinds amid stable feed costs.

Read more
Tuesday, November 11, 2025 - 1:42pm
Medtronic logo is seen at its office in Irvine, California

BofA expects Medtronic to post over 5% second-quarter revenue growth and maintain strong momentum through 2026, driven by robust procedure trends.

Read more
Tuesday, November 11, 2025 - 1:11pm
Velo3D sign in Campbell, CA.

Shares of Velo3D, Inc. (NASDAQ:VELO) are rising Tuesday after the metal 3D printing company reported third-quarter earnings results.

Read more
Earnings, News, Movers
Tuesday, November 11, 2025 - 1:09pm
Occidental Petroleum logo on the website homepage.

Analysts highlight OXY's robust earnings, production guidance, and expanded resource base as key growth drivers.

Read more
Tuesday, November 11, 2025 - 1:00pm
eToro

EToro Group shares are trading higher on Tuesday. The trading and investing platform company reported strong third-quarter results.

Read more
Earnings, News, Financing, Movers
Tuesday, November 11, 2025 - 12:52pm
Various Nike sneakers displayed around "Just Do It" sign.

Bank of America maintains Buy rating on Nike with $84 price target, citing expectations of sales and margin recovery.

Read more
Tuesday, November 11, 2025 - 12:51pm
Pills and medicine in capsules on the missing puzzle piece, concept of generics, clinical trial of drugs.

Neurocrine's Phase 2 trial of NBI-1070770 in major depressive disorder missed its main goal but showed good safety and strong Q3 financial results.

Read more